 Misha Miller
Concepts (62)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Women's Health | 2 | 2018 | 314 | 0.670 |
Why?
| | Vaginal Diseases | 1 | 2018 | 19 | 0.570 |
Why?
| | Skin Neoplasms | 4 | 2022 | 848 | 0.540 |
Why?
| | Nose Neoplasms | 1 | 2017 | 21 | 0.530 |
Why?
| | Dermatologic Surgical Procedures | 1 | 2017 | 23 | 0.520 |
Why?
| | Rhinoplasty | 1 | 2017 | 39 | 0.500 |
Why?
| | Laser Therapy | 1 | 2018 | 142 | 0.500 |
Why?
| | Vagina | 1 | 2018 | 202 | 0.480 |
Why?
| | Surgical Flaps | 1 | 2017 | 142 | 0.480 |
Why?
| | Catheter Ablation | 1 | 2018 | 355 | 0.430 |
Why?
| | Referral and Consultation | 1 | 2018 | 862 | 0.360 |
Why?
| | Hyperkeratosis, Epidermolytic | 1 | 2005 | 21 | 0.230 |
Why?
| | Genital Diseases, Female | 1 | 2005 | 31 | 0.230 |
Why?
| | Skin Diseases, Vesiculobullous | 1 | 2005 | 17 | 0.220 |
Why?
| | Pregnancy Outcome | 1 | 2005 | 500 | 0.170 |
Why?
| | Pregnancy Complications | 1 | 2005 | 600 | 0.150 |
Why?
| | Atrophy | 1 | 2018 | 198 | 0.140 |
Why?
| | Foot Dermatoses | 1 | 2017 | 4 | 0.130 |
Why?
| | Skin Care | 1 | 2017 | 22 | 0.130 |
Why?
| | Postmenopause | 1 | 2018 | 391 | 0.120 |
Why?
| | Wound Healing | 1 | 2017 | 354 | 0.100 |
Why?
| | Melanoma | 2 | 2017 | 759 | 0.090 |
Why?
| | Pregnancy, Multiple | 1 | 2005 | 19 | 0.060 |
Why?
| | Remission, Spontaneous | 1 | 2005 | 39 | 0.060 |
Why?
| | Pruritus | 1 | 2005 | 59 | 0.050 |
Why?
| | Rare Diseases | 1 | 2005 | 116 | 0.050 |
Why?
| | Pregnancy Trimester, Third | 1 | 2005 | 118 | 0.050 |
Why?
| | Urticaria | 1 | 2005 | 38 | 0.050 |
Why?
| | Biopsy, Needle | 1 | 2005 | 185 | 0.050 |
Why?
| | Twins | 1 | 2005 | 151 | 0.050 |
Why?
| | Infusions, Intravenous | 1 | 2005 | 428 | 0.050 |
Why?
| | Humans | 7 | 2022 | 145140 | 0.050 |
Why?
| | Middle Aged | 3 | 2017 | 36126 | 0.050 |
Why?
| | Mohs Surgery | 1 | 2022 | 29 | 0.050 |
Why?
| | Facial Nerve | 1 | 2022 | 39 | 0.050 |
Why?
| | Adrenal Cortex Hormones | 1 | 2005 | 483 | 0.040 |
Why?
| | Diagnosis, Differential | 1 | 2005 | 1506 | 0.040 |
Why?
| | Immunohistochemistry | 1 | 2005 | 1713 | 0.040 |
Why?
| | Female | 4 | 2018 | 78636 | 0.040 |
Why?
| | Antineoplastic Agents | 1 | 2010 | 2207 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2005 | 2928 | 0.030 |
Why?
| | Membranes, Artificial | 1 | 2017 | 68 | 0.030 |
Why?
| | Skin Transplantation | 1 | 2017 | 85 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2022 | 1146 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2005 | 5411 | 0.030 |
Why?
| | Pregnancy | 1 | 2005 | 7182 | 0.020 |
Why?
| | Aminolevulinic Acid | 1 | 2010 | 4 | 0.020 |
Why?
| | Injections, Intralesional | 1 | 2010 | 35 | 0.020 |
Why?
| | Male | 1 | 2017 | 72664 | 0.020 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2010 | 95 | 0.020 |
Why?
| | Fluorouracil | 1 | 2010 | 230 | 0.020 |
Why?
| | Rituximab | 1 | 2010 | 210 | 0.020 |
Why?
| | Interferon-alpha | 1 | 2010 | 193 | 0.020 |
Why?
| | Methotrexate | 1 | 2010 | 233 | 0.020 |
Why?
| | Interleukin-2 | 1 | 2010 | 440 | 0.020 |
Why?
| | Lymphoma, B-Cell | 1 | 2010 | 137 | 0.020 |
Why?
| | Bleomycin | 1 | 2010 | 255 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2010 | 688 | 0.020 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2010 | 640 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2022 | 17247 | 0.010 |
Why?
| | Adult | 1 | 2005 | 40665 | 0.010 |
Why?
| | Aged | 1 | 2017 | 26096 | 0.010 |
Why?
|
|
Miller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|